InMode Ltd. (INMD) vs SpyGlass Pharma, Inc. Common Stock (SGP)
A side-by-side comparison of InMode Ltd. and SpyGlass Pharma, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INMD
InMode Ltd.
$13.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SGP
SpyGlass Pharma, Inc. Common Stock
$24.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INMD vs SGP
growth of $100 · dividends reinvested · last 1yINMD -4.7% (-4.7%/yr)SGP -3.1% (-3.1%/yr)SGP compounded faster over this window
INMD SGP
INMD vs SGP: by the numbers
- •SGP is the larger company ($828M vs $804M market cap).
- •INMD is profitable (20.69% net margin) while SGP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | INMD | SGP |
|---|---|---|
| P/E ratio | 11.37 | N/A |
| Forward P/E | 10.79 | N/A |
| PEG ratio | 1.14 | N/A |
| P/S ratio | 2.15 | N/A |
| P/B ratio | 1.28 | 3.57 |
| EV / EBITDA | 5.90 | N/A |
| FCF yield | 10.88% | N/A |
Profitability
| Metric | INMD | SGP |
|---|---|---|
| Gross margin | 76.52% | 0.00% |
| Operating margin | 18.47% | 0.00% |
| Net margin | 20.69% | 0.00% |
| ROE | 12.32% | -24.12% |
| ROIC | 9.20% | -26.54% |
Growth (annualized)
| Metric | INMD | SGP |
|---|---|---|
| Revenue CAGR (5Y) | 5.42% | N/A |
| EPS CAGR (5Y) | 6.87% | N/A |
| FCF CAGR (5Y) | 1.36% | N/A |
| Total return CAGR (5Y) | -27.48% | N/A |
Frequently asked
- Is INMD or SGP more profitable?
- INMD runs the higher net margin — INMD at 20.69% versus SGP at 0.00%.
Go deeper
Dig into the metrics
InMode P/E ratioInMode ROESpyGlass Pharma, Inc. Common Stock ROEInMode operating marginSpyGlass Pharma, Inc. Common Stock operating marginInMode revenue growthSpyGlass Pharma, Inc. Common Stock revenue growthInMode free cash flowSpyGlass Pharma, Inc. Common Stock free cash flow
InMode & SpyGlass Pharma, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.